EMA Tries to Allay More Concerns About Data Redaction

Drug Industry Daily
A A
European regulators yesterday told the European Union ombudsman that they adhered to the law when allowing manufacturer AbbVie to redact information from its clinical study reports, marking the latest twist in the debate over European trial data transparency.

To View This Article:

Login

Subscribe To Drug Industry Daily